Inventor · disambiguated record
Bismarck Campos
Also filed as: CAMPOS BISMARCK
7 granted patents·3 pending applications·8 citations·filing 2011–2023
75Inventor score
Top patents by PatentIndex Score
10 records- 0182US8653108B1Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitorsMCHARDY STANTON F·Filed 2012·Granted Feb 18, 2014·5 cites·13 claims
- 0278US8772345B2Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitorsMCHARDY STANTON F·Filed 2011·Granted Jul 8, 2014·3 cites·7 claims
- 0375US2023271926A1Inhibition of olig2 activityCURTANA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0468US11691951B2Inhibition of Olig2 activityCURTANA PHARMACEUTICALS INC·Filed 2021·Granted Jul 4, 2023·0 cites·8 claims
- 0567US12145913B2Inhibition of Olig2 activityCURTANA PHARMACEUTICALS INC·Filed 2021·Granted Nov 19, 2024·0 cites·6 claims
- 0665US2021114991A1Inhibition of olig2 activityCURTANA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0764US9169220B2Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitorsSOUTHWEST RES INST·Filed 2014·Granted Oct 27, 2015·0 cites·10 claims
- 0853US11242323B2Inhibition of OLIG2 activityCURTANA PHARMACEUTICALS INC·Filed 2017·Granted Feb 8, 2022·0 cites·15 claims
- 0948US2018244631A1Inhibition of olig2 activityCURTANA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1047US11685722B2Inhibition of Olig2 activityCURTANA PHARMACEUTICALS INC·Filed 2019·Granted Jun 27, 2023·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Bismarck Campos files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →